Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 73 entries
Sorted by: Best Match Show Resources per page
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.

Transplantation direct

Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C.
PMID: 28573191
Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May.

BACKGROUND: Invasive fungal infections remain a leading cause of morbidity and mortality among liver transplant recipients (LTRs). In this patient population, invasive Candida infections (ICIs) account for the large majority of cases. To date, only small studies and case-series...

Cite
Bassetti M, Peghin M, Carnelutti A, et al. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017;3(5):e156doi: 10.1097/TXD.0000000000000673.
Bassetti, M., Peghin, M., Carnelutti, A., Righi, E., Merelli, M., Ansaldi, F., Trucchi, C., Alicino, C., Sartor, A., Wauters, J., Lagrou, K., Tascini, C., Menichetti, F., Mesini, A., De Rosa, F. G., Lagunes, L., Rello, J., Colombo, A. L., Vena, A., Munoz, P., Tumbarello, M., Sganga, G., Martin-Loeches, I., & Viscoli, C. (2017). Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplantation direct, 3(5), e156. https://doi.org/10.1097/TXD.0000000000000673
Bassetti, Matteo, et al. "Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality." Transplantation direct vol. 3,5 (2017): e156. doi: https://doi.org/10.1097/TXD.0000000000000673
Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May. PMID: 28573191; PMCID: PMC5441987.
Copy Download .nbib Format: NLM
[Bacterial pneumonia in HIV-infected patients].

Le infezioni in medicina

De Gaetano Donati K, Tacconelli E, Tumbarello M, Bertagnolo S, Ardito F, Pirronti T, Cauda R.
PMID: 12759590
Infez Med. 1999;7(2):108-112.

This case-control study assessed risk factors and prognostic indicators of 350 episodes of bacterial pneumonia in 285 HIV-infected patients. On univariate analysis, intravenous drug abuse (p

Cite
De Gaetano Donati K, Tacconelli E, Tumbarello M, et al. Polmoniti batteriche in corso di infezioni da HIV. [Bacterial pneumonia in HIV-infected patients]. Infez Med. 1999;7(2):108-112
De Gaetano Donati, K., Tacconelli, E., Tumbarello, M., Bertagnolo, S., Ardito, F., Pirronti, T., & Cauda, R. (1999). Polmoniti batteriche in corso di infezioni da HIV. [Bacterial pneumonia in HIV-infected patients]. Le infezioni in medicina, 7(2), 108-112.
De Gaetano Donati, K., et al. "Polmoniti batteriche in corso di infezioni da HIV." [Bacterial pneumonia in HIV-infected patients]. Le infezioni in medicina vol. 7,2 (1999): 108-112.
De Gaetano Donati K, Tacconelli E, Tumbarello M, Bertagnolo S, Ardito F, Pirronti T, Cauda R. Polmoniti batteriche in corso di infezioni da HIV. [Bacterial pneumonia in HIV-infected patients]. Infez Med. 1999;7(2):108-112. Italian. PMID: 12759590.
Copy Download .nbib Format: NLM
Morgagni's diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report.

Journal of medical case reports

Bassareo PP, Neroni P, Montis S, Tumbarello R.
PMID: 21143832
J Med Case Rep. 2010 Dec 08;4:395. doi: 10.1186/1752-1947-4-395.

INTRODUCTION: Morgagni's congenital diaphragmatic defect is a rare malformation, the diagnosis of which, as in our case report, may be problematic. To the best of our knowledge, this is the first report of this kind of hernia presenting with...

Cite
Bassareo PP, Neroni P, Montis S, et al. Morgagni's diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report. J Med Case Rep. 2010;4:395doi: 10.1186/1752-1947-4-395.
Bassareo, P. P., Neroni, P., Montis, S., & Tumbarello, R. (2010). Morgagni's diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report. Journal of medical case reports, 4395. https://doi.org/10.1186/1752-1947-4-395
Bassareo, Pier Paolo, et al. "Morgagni's diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report." Journal of medical case reports vol. 4 (2010): 395. doi: https://doi.org/10.1186/1752-1947-4-395
Bassareo PP, Neroni P, Montis S, Tumbarello R. Morgagni's diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report. J Med Case Rep. 2010 Dec 08;4:395. doi: 10.1186/1752-1947-4-395. PMID: 21143832; PMCID: PMC3017073.
Copy Download .nbib Format: NLM
Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?.

Intensive care medicine

Bassetti M, Akova M, Tumbarello M.
PMID: 30413839
Intensive Care Med. 2018 Dec;44(12):2324. doi: 10.1007/s00134-018-5411-6.

The original version of this article unfortunately contained a mistake.

Cite
Bassetti M, Akova M, Tumbarello M. Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?. Intensive Care Med. 2018;44(12):2324doi: 10.1007/s00134-018-5411-6.
Bassetti, M., Akova, M., & Tumbarello, M. (2018). Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?. Intensive care medicine, 44(12), 2324. https://doi.org/10.1007/s00134-018-5411-6
Bassetti, Matteo, et al. "Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?." Intensive care medicine vol. 44,12 (2018): 2324. doi: https://doi.org/10.1007/s00134-018-5411-6
Bassetti M, Akova M, Tumbarello M. Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?. Intensive Care Med. 2018 Dec;44(12):2324. doi: 10.1007/s00134-018-5411-6. PMID: 30413839.
Copy Download .nbib Format: NLM
Tidal volume in acute respiratory distress syndrome: how best to select it.

Annals of translational medicine

Umbrello M, Marino A, Chiumello D.
PMID: 28828362
Ann Transl Med. 2017 Jul;5(14):287. doi: 10.21037/atm.2017.06.51.

Mechanical ventilation is the type of organ support most widely provided in the intensive care unit. However, this form of support does not constitute a cure for acute respiratory distress syndrome (ARDS), as it mainly works by buying time...

Cite
Umbrello M, Marino A, Chiumello D. Tidal volume in acute respiratory distress syndrome: how best to select it. Ann Transl Med. 2017;5(14):287doi: 10.21037/atm.2017.06.51.
Umbrello, M., Marino, A., & Chiumello, D. (2017). Tidal volume in acute respiratory distress syndrome: how best to select it. Annals of translational medicine, 5(14), 287. https://doi.org/10.21037/atm.2017.06.51
Umbrello, Michele, et al. "Tidal volume in acute respiratory distress syndrome: how best to select it." Annals of translational medicine vol. 5,14 (2017): 287. doi: https://doi.org/10.21037/atm.2017.06.51
Umbrello M, Marino A, Chiumello D. Tidal volume in acute respiratory distress syndrome: how best to select it. Ann Transl Med. 2017 Jul;5(14):287. doi: 10.21037/atm.2017.06.51. PMID: 28828362; PMCID: PMC5537119.
Copy Download .nbib Format: NLM
Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients.

Journal of critical care

Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D.
PMID: 34952476
J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21.

PURPOSE: Several different tools have been developed to integrate the clinical and biochemical nutritional evaluations in critical care patients. Aims of this study were to evaluate the changes in the Bioelectrical Impedance Vector Analysis (BIVA) and ultrasonographic features of...

Cite
Formenti P, Coppola S, Umbrello M, et al. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021;68:89-95doi: 10.1016/j.jcrc.2021.11.014.
Formenti, P., Coppola, S., Umbrello, M., Froio, S., Cacioppola, A., De Giorgis, V., Galanti, V., Lusardi, A. C., Ferrari, E., Noè, D., Carnier, S., Folli, F., & Chiumello, D. (2021). Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. Journal of critical care, 6889-95. https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti, Paolo, et al. "Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients." Journal of critical care vol. 68 (2021): 89-95. doi: https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21. PMID: 34952476.
Copy Download .nbib Format: NLM
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement.

Respiratory medicine

Blasi F, Di Pasquale M, Gramegna A, Viale P, Iacobello C, Gori A, Tumbarello M, Esposito S, Richeldi L, Bassetti M.
PMID: 34788734
Respir Med. 2021 Dec;190:106674. doi: 10.1016/j.rmed.2021.106674. Epub 2021 Nov 01.

Influenza and pneumococcal disease represent a well-known burden on healthcare systems worldwide, as well as they still have an attributed morbidity and mortality, especially in elderly individuals and vulnerable populations. In the context of the ongoing pandemic of COVID-19,...

Cite
Blasi F, Di Pasquale M, Gramegna A, et al. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respir Med. 2021;190:106674doi: 10.1016/j.rmed.2021.106674.
Blasi, F., Di Pasquale, M., Gramegna, A., Viale, P., Iacobello, C., Gori, A., Tumbarello, M., Esposito, S., Richeldi, L., & Bassetti, M. (2021). A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respiratory medicine, 190106674. https://doi.org/10.1016/j.rmed.2021.106674
Blasi, Francesco, et al. "A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement." Respiratory medicine vol. 190 (2021): 106674. doi: https://doi.org/10.1016/j.rmed.2021.106674
Blasi F, Di Pasquale M, Gramegna A, Viale P, Iacobello C, Gori A, Tumbarello M, Esposito S, Richeldi L, Bassetti M. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respir Med. 2021 Dec;190:106674. doi: 10.1016/j.rmed.2021.106674. Epub 2021 Nov 01. PMID: 34788734; PMCID: PMC8559458.
Copy Download .nbib Format: NLM
Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients.

Journal of critical care

Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D.
PMID: 34952476
J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21.

PURPOSE: Several different tools have been developed to integrate the clinical and biochemical nutritional evaluations in critical care patients. Aims of this study were to evaluate the changes in the Bioelectrical Impedance Vector Analysis (BIVA) and ultrasonographic features of...

Cite
Formenti P, Coppola S, Umbrello M, et al. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021;68:89-95doi: 10.1016/j.jcrc.2021.11.014.
Formenti, P., Coppola, S., Umbrello, M., Froio, S., Cacioppola, A., De Giorgis, V., Galanti, V., Lusardi, A. C., Ferrari, E., Noè, D., Carnier, S., Folli, F., & Chiumello, D. (2021). Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. Journal of critical care, 6889-95. https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti, Paolo, et al. "Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients." Journal of critical care vol. 68 (2021): 89-95. doi: https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21. PMID: 34952476.
Copy Download .nbib Format: NLM
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells.

Endocrinology

Abate A, Rossini E, Tamburello M, Laganà M, Cosentini D, Grisanti S, Fiorentini C, Tiberio GAM, Scatolini M, Grosso E, Hantel C, Memo M, Berruti A, Sigala S.
PMID: 34875044
Endocrinology. 2021 Dec 07; doi: 10.1210/endocr/bqab248. Epub 2021 Dec 07.

Mitotane is the only approved drug for the treatment of adrenocortical carcinoma (ACC). The regimen to be added to mitotane is a chemotherapy with etoposide, doxorubicin, and cisplatin. This pharmacological approach, however, has a limited efficacy and significant toxicity....

Cite
Abate A, Rossini E, Tamburello M, et al. Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells. Endocrinology. 2021;doi: 10.1210/endocr/bqab248.
Abate, A., Rossini, E., Tamburello, M., Laganà, M., Cosentini, D., Grisanti, S., Fiorentini, C., Tiberio, G. A. M., Scatolini, M., Grosso, E., Hantel, C., Memo, M., Berruti, A., & Sigala, S. (2021). Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells. Endocrinology, . https://doi.org/10.1210/endocr/bqab248
Abate, Andrea, et al. "Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells." Endocrinology vol. (2021). doi: https://doi.org/10.1210/endocr/bqab248
Abate A, Rossini E, Tamburello M, Laganà M, Cosentini D, Grisanti S, Fiorentini C, Tiberio GAM, Scatolini M, Grosso E, Hantel C, Memo M, Berruti A, Sigala S. Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells. Endocrinology. 2021 Dec 07; doi: 10.1210/endocr/bqab248. Epub 2021 Dec 07. PMID: 34875044.
Copy Download .nbib Format: NLM
Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study.

Antibiotics (Basel, Switzerland)

Giacobbe DR, Mirabella M, Rinaldi M, Losito AR, Raffaelli F, Del Puente F, Saffioti C, Mikulska M, Giannella M, Viale P, Tumbarello M, Bassetti M, On Behalf Of Sita Giovani Young Investigators Group Of The Società Italiana Terapia Antinfettiva And.
PMID: 34943767
Antibiotics (Basel). 2021 Dec 19;10(12). doi: 10.3390/antibiotics10121554.

Colistin is a last-resort agent for the treatment of infections due to Gram-negative bacteria with difficult-to-treat resistance. The primary objective of this post hoc analysis of a cross-sectional study conducted in 22 Italian hospitals was to assess factors associated...

Cite
Giacobbe DR, Mirabella M, Rinaldi M, et al. Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study. Antibiotics (Basel). 2021;10(12)doi: 10.3390/antibiotics10121554.
Giacobbe, D. R., Mirabella, M., Rinaldi, M., Losito, A. R., Raffaelli, F., Del Puente, F., Saffioti, C., Mikulska, M., Giannella, M., Viale, P., Tumbarello, M., Bassetti, M., & On Behalf Of Sita Giovani Young Investigators Group Of The Società Italiana Terapia Antinfettiva And. (2021). Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study. Antibiotics (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antibiotics10121554
Giacobbe, Daniele Roberto, et al. "Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study." Antibiotics (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antibiotics10121554
Giacobbe DR, Mirabella M, Rinaldi M, Losito AR, Raffaelli F, Del Puente F, Saffioti C, Mikulska M, Giannella M, Viale P, Tumbarello M, Bassetti M, On Behalf Of Sita Giovani Young Investigators Group Of The Società Italiana Terapia Antinfettiva And. Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study. Antibiotics (Basel). 2021 Dec 19;10(12). doi: 10.3390/antibiotics10121554. PMID: 34943767.
Copy Download .nbib Format: NLM
Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients.

Journal of critical care

Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D.
PMID: 34952476
J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21.

PURPOSE: Several different tools have been developed to integrate the clinical and biochemical nutritional evaluations in critical care patients. Aims of this study were to evaluate the changes in the Bioelectrical Impedance Vector Analysis (BIVA) and ultrasonographic features of...

Cite
Formenti P, Coppola S, Umbrello M, et al. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021;68:89-95doi: 10.1016/j.jcrc.2021.11.014.
Formenti, P., Coppola, S., Umbrello, M., Froio, S., Cacioppola, A., De Giorgis, V., Galanti, V., Lusardi, A. C., Ferrari, E., Noè, D., Carnier, S., Folli, F., & Chiumello, D. (2021). Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. Journal of critical care, 6889-95. https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti, Paolo, et al. "Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients." Journal of critical care vol. 68 (2021): 89-95. doi: https://doi.org/10.1016/j.jcrc.2021.11.014
Formenti P, Coppola S, Umbrello M, Froio S, Cacioppola A, De Giorgis V, Galanti V, Lusardi AC, Ferrari E, Noè D, Carnier S, Folli F, Chiumello D. Time course of the Bioelectrical Impedance Vector Analysis and muscular ultrasound in critically ill patients. J Crit Care. 2021 Dec 21;68:89-95. doi: 10.1016/j.jcrc.2021.11.014. Epub 2021 Dec 21. PMID: 34952476.
Copy Download .nbib Format: NLM
Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data.

Infection and drug resistance

Giacobbe DR, Ciacco E, Girmenia C, Pea F, Rossolini GM, Sotgiu G, Tascini C, Tumbarello M, Viale P, Bassetti M.
PMID: 33402840
Infect Drug Resist. 2020 Dec 29;13:4697-4711. doi: 10.2147/IDR.S205309. eCollection 2020.

Infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB), especially when carbapenem resistant, have been very difficult to manage in the last fifteen years, owing to the paucity of dependable therapeutic options. Cefiderocol is a siderophore cephalosporin recently approved by the...

Cite
Giacobbe DR, Ciacco E, Girmenia C, et al. Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data. Infect Drug Resist. 2020;13:4697-4711doi: 10.2147/IDR.S205309.
Giacobbe, D. R., Ciacco, E., Girmenia, C., Pea, F., Rossolini, G. M., Sotgiu, G., Tascini, C., Tumbarello, M., Viale, P., Bassetti, M. (2020). Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data. Infection and drug resistance, 134697-4711. https://doi.org/10.2147/IDR.S205309
Giacobbe, Daniele Roberto, et al. "Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data." Infection and drug resistance vol. 13 (2020): 4697-4711. doi: https://doi.org/10.2147/IDR.S205309
Giacobbe DR, Ciacco E, Girmenia C, Pea F, Rossolini GM, Sotgiu G, Tascini C, Tumbarello M, Viale P, Bassetti M. Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data. Infect Drug Resist. 2020 Dec 29;13:4697-4711. doi: 10.2147/IDR.S205309. eCollection 2020. PMID: 33402840; PMCID: PMC7778378.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 73 entries